Literature DB >> 1721346

The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis.

K Nakamura1, A Yagihashi, Y Iwaki, S Takaya, G G Hartman, N Murase, O Bronsther, R Manez, J J Fung, S Iwatsuki.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1721346      PMCID： PMC3082457     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.

Authors:  S Takaya; R Duquesnoy; Y Iwaki; J Demetris; A Yagihashi; O Bronsther; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization.

Authors:  G Gubernatis; W Lauchart; M Jonker; G Steinhoff; A Bornscheuer; P Neuhaus; A A van Es; J Kemnitz; K Wonigeit; R Pichlmayr
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

3.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

4.  Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers.

Authors:  A J Demetris; R Jaffe; A Tzakis; G Ramsey; S Todo; S Belle; C Esquivel; R Shapiro; B Markus; E Mroczek
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

Review 5.  Immunopathology of liver transplantation.

Authors:  A J Demetris; B H Markus
Journal:  Crit Rev Immunol       Date:  1989       Impact factor: 2.214

6.  Extended preservation of human liver grafts with UW solution.

Authors:  S Todo; J Nery; K Yanaga; L Podesta; R D Gordon; T E Starzl
Journal:  JAMA       Date:  1989-02-03       Impact factor: 56.272

7.  Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen.

Authors:  A J Demetris; S Lasky; D H Van Thiel; T E Starzl; A Dekker
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307
  7 in total
  4 in total

1.  Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.

Authors:  Jacqueline G O'Leary; Hugo Kaneku; Anthony J Demetris; John D Marr; S Michelle Shiller; Brian M Susskind; Glenn W Tillery; Paul I Terasaki; Göran B Klintmalm
Journal:  Liver Transpl       Date:  2014-01-02       Impact factor: 5.799

Review 2.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 3.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch.

Authors:  M Kobayashi; A Yagihashi; R Manez; S Takaya; K Noguchi; A Konno; Y Kita; Y Yoshida; K Terasawa; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.